The final numbers are in, and now it's official – digital health companies raked in a massive $57.2 billion in funding last year, beating prior records with a 79% increase over 2020.
Johnson & Johnson has said the impending spin-off of its consumer health division won't stop it from "forging ahead" with M&A deals to expand its other businesses including pharma a
The latest pharma company to make a move for an mRNA specialist is Germany's Merck KGaA, which has offered a $780 million cash buyout to US biotech Exelead.
Push Doctor – a digital platform that virtually connects patients with GPs – has been acquired by private healthcare service provider Square Health for an undisclosed fee.
Gyroscope Therapeutics and its gene therapy for the sight-robbing disease geographic atrophy (GA) has been acquired by a big pharma company – but likely not the one you would expect.
